Differentiated thyroid cancer in childhood;Cancer differencié de la thyroïde de l'enfant

Bulletin du Cancer

Volumn 99, Issue 11, 2012, Pages 1093-1099

  Leboulleux, Sophie ^a   Hartl, Dana ^a   Baudin, Éric ^a   Schlumberger, Martin ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Childhood; Diagnosis; Differentiated thyroid cancer; Prognosis; Treatment

Indexed keywords

THYROXINE;

CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CHILDHOOD CANCER; DIFFERENTIATED THYROID CANCER; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; REVIEW; THYROIDECTOMY;

EID: 84871114224     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2012.1645     Document Type: Article

References (40)

1. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19 : 1167-214.
2. Borson-Chazot F, Bardet S, Bournaud C, et al. Guidelines for the management of differentiated thyroid carcinomas of vesicular origin. Ann Endocrinol (Paris) 2008; 69 : 472-86.
3. Hay ID, Gonzalez-Losada T, Reinalda MS, Honetschlager JA, Richards ML, Thompson GB. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 2010; 34 : 1192-202.
4. Enomoto Y, Enomoto K, Uchino S, Shibuya H, Watanabe S, Noguchi S. Clinical features, treatment, and long-term outcome of papillary thyroid cancer in children and adolescents without radiation exposure. World J Surg 2012; 36 : 1241-6.
5. Schlumberger M, De Vathaire F, Travagli JP, et al. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab 1987; 65 : 1088-94. (Pubitemid 18026839)
6. Dottorini ME, Vignati A, Mazzucchelli L, Lomuscio G, Colombo L. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med 1997; 38 : 669-75. (Pubitemid 27204036)
7. Handkiewicz-Junak D, Wloch J, Roskosz J, et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. J Nucl Med 2007; 48 : 879-88. (Pubitemid 46909915)
8. Demidchik YE, Demidchik EP, Reiners C, et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg 2006; 243 : 525-32.
9. Welch Dinauer CA, Tuttle RM, Robie DK, et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf) 1998; 49 : 619-28. (Pubitemid 28529761)
10. Vassilopoulou-Sellin R, Goepfert H, Raney B, Schultz PN. Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up. Head Neck 1998; 20 : 549-55. (Pubitemid 28361461)
11. Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 2007; 92 : 3590-4. (Pubitemid 47435339)
12. Leenhardt L, Borson-Chazot F, Calzada M, et al. Good practice guide for cervical ultrasound scan and echo-guided techniques in treating differentiated thyroid cancer of vesicular origin. Ann Endocrinol (Paris) 2011; 72 : 173-97.
13. Richards ML. Familial syndromes associated with thyroid cancer in the era of personalized medicine. Thyroid 2010; 20 : 707-13.
14. Cantara S, Pisu M, Frau DV, et al. Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer. J Clin Endocrinol Metab 2012; 97 : E1327-31.
15. Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet 2008; 16 : 1289-300.
16. Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J Rare Dis 2009; 4 : 22.
17. Ishikawa Y, Sugano H, Matsumoto T, Furuichi Y, Miller RW, Goto M. Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer 1999; 85 : 1345-52. (Pubitemid 29125089)
18. Sinnott B, Ron E, Schneider AB. Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev 2010; 31 : 756-73.
19. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141 : 259-77.
20. Sigurdson AJ, Ronckers CM, Mertens AC, et al. Primary thyroid cancer after a first tumour in childhood (the childhood cancer survivor study): a nested case-control study. Lancet 2005; 365 : 2014-23. (Pubitemid 40805009)
21. Sankila R, Garwicz S, Olsen JH, et al. Risk of subsequent malignant neoplasms among 1641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology. J Clin Oncol 1996; 14 : 1442-6. (Pubitemid 26134199)
22. Davies SM. Subsequent malignant neoplasms in survivors of childhood cancer: Childhood Cancer Survivor Study (CCSS) studies. Pediatr Blood Cancer 2007; 48 : 727-30. (Pubitemid 46717627)
23. Maule M, Scelo G, Pastore G, et al. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study. Eur J Cancer 2008; 44 : 830-9.
24. Tucker MA, Jones PH, Boice Jr. JD, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 1991; 51 : 2885-8.
25. Koo JS, Hong S, Park CS. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young. Thyroid 2009; 19 : 1225-31.
26. Sassolas G, Hafdi-Nejjari Z, Ferraro A, et al. Oncogenic alterations in papillary thyroid cancers of young patients. Thyroid 2012; 22 : 17-26.
27. Nikirov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 1997; 57 : 1690-4. (Pubitemid 27199660)
28. Bongarzone I, Fugazzola L, Vigneri P, et al. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin Endocrinol Metab 1996; 81 : 2006-9. (Pubitemid 26152500)
29. Fenton CL, Lukes Y, Nicholson D, Dinauer CA, Francis GL, Tuttle RM. The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. J Clin Endocrinol Metab 2000; 85 : 1170-5. (Pubitemid 32269367)
30. Lima J, Trovisco V, Soares P, et al. BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J Clin Endocrinol Metab 2004; 89 : 4267-71. (Pubitemid 39244424)
31. Yamashita S, Saenko V. Mechanisms of disease: molecular genetics of childhood thyroid cancers. Nat Clin Pract Endocrinol Metab 2007; 3 : 422-9. (Pubitemid 46650671)
32. Nikiforova MN, Nikiforov YE. Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009; 19 : 1351-61.
33. Rivkees SA, Mazzaferri EL, Verburg FA, et al. The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. Endocr Rev 2012; 32 : 798-826.
34. Luster M, Lassmann M, Freudenberg LS, Reiners C. Thyroid cancer in childhood: management strategy, including dosimetry and long-term results. Hormones (Athens) 2007; 6 : 269-78.
35. Thompson GB, Hay ID. Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma. World J Surg 2004; 28 : 1187-98. (Pubitemid 40941277)
36. th ed. Singapore: Blackwell Publishing Ldt, 2010, p. 58-62.
37. Brassard M, Neraud B, Trabado S, et al. Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer. J Clin Endocrinol Metab 2011; 96 : 2741-9.
38. Travagli JP, Cailleux AF, Ricard M, et al. Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 1998; 83 : 2675-80. (Pubitemid 28493759)
39. Hartl DM, Chami L, Al Ghuzlan A, et al. Charcoal suspension tattoo localization for differentiated thyroid cancer recurrence. Ann Surg Oncol 2009; 16 : 2602-8.
40. Kang TW, Shin JH, Han BK, et al. Preoperative ultrasound-guided tattooing localization of recurrences after thyroidectomy: safety and effectiveness. Ann Surg Oncol 2009; 16 : 1655-9.